NASDAQ:RCM

R1 RCM Stock Forecast, Price & News

$21.97

+1.01 (+4.82%)

(As of 07/1/2022 08:45 PM ET)

Add

Compare

Today's Range: $20.77
▼
$21.99
50-Day Range: $19.11
▼
$25.00
52-Week Range: $18.71
▼
$27.86

Volume: 1.14 million shs
Average Volume: 1.26 million shs
Market Capitalization: $6.15 billion

P/E Ratio: 70.87
Dividend Yield: N/A
Price Target: $29.00

R1 RCM MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.88 Rating Score
Upside/Downside: 32.0% Upside
$29.00 Price Target
Short Interest: Bearish
2.40% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -1.12
Upright™ Environmental Score
News Sentiment: -0.32
Based on 22 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 54.17%
From $0.48 to $0.74 Per Share

Overall MarketRank^™

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.36 out of 5 stars

Business Services Sector

48th out of 466 stocks

Management Services Industry

2nd out of 8 stocks

3.4 Analyst's Opinion

Consensus Rating
R1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $29.00, R1 RCM has a forecasted upside of 32.0% from its current price of $21.97.
Amount of Analyst Coverage
R1 RCM has only been the subject of 3 research reports in the past 90 days.

2.0 Short Interest

Percentage of Shares Shorted
2.40% of the outstanding shares of R1 RCM have been sold short.
Short Interest Ratio / Days to Cover
R1 RCM has a short interest ratio ("days to cover") of 5.4.
Change versus previous month
Short interest in R1 RCM has recently increased by 6.69%, indicating that investor sentiment is decreasing significantly.

0.0 Dividend Strength

Dividend Yield
R1 RCM does not currently pay a dividend.
Dividend Growth
R1 RCM does not have a long track record of dividend growth.

3.0 Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
R1 RCM has received a 49.95% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Taxes". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Patient flow management systems", "Personal health record software", and "Documentation software for clinicians" products. See details.
Environmental Sustainability
The Environmental Impact score for R1 RCM is -1.12.

2.0 News and Social Media Coverage

News Sentiment
R1 RCM has a news sentiment score of -0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 22 news articles for R1 RCM this week, compared to 2 articles on an average week.
Search Interest
2 people have searched for RCM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
1 people have added R1 RCM to their MarketBeat watchlist in the last 30 days.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, R1 RCM insiders have not sold or bought any company stock.
Percentage Held by Insiders
59.40% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
41.97% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for R1 RCM are expected to grow by 54.17% in the coming year, from $0.48 to $0.74 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of R1 RCM is 70.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 67.65.
Price to Earnings Ratio vs. Sector
The P/E ratio of R1 RCM is 70.87, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 16.59.
Price to Earnings Growth Ratio
R1 RCM has a PEG Ratio of 2.54. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
R1 RCM has a P/B Ratio of 17.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Murray, Utah.

July 3, 2022 | americanbankingnews.com

R1 RCM Inc. (NASDAQ:RCM) Receives $29.00 Average Target Price from Brokerages

July 2, 2022 | americanbankingnews.com

R1 RCM (NASDAQ:RCM) Price Target Cut to $26.00 by Analysts at Deutsche Bank Aktiengesellschaft

July 1, 2022 | americanbankingnews.com

Barclays Reiterates "Overweight" Rating for R1 RCM (NASDAQ:RCM)

June 30, 2022 | americanbankingnews.com

R1 RCM Inc. Expected to Earn Q2 2022 Earnings of $0.06 Per Share (NASDAQ:RCM)

June 28, 2022 | seekingalpha.com

R1 RCM updates guidance to higher end post Cloudmed acquisition

June 28, 2022 | americanbankingnews.com

R1 RCM Inc. Expected to Earn Q2 2022 Earnings of $0.07 Per Share (NASDAQ:RCM)

June 26, 2022 | americanbankingnews.com

R1 RCM (NASDAQ:RCM) Sees Large Volume Increase

June 24, 2022 | finance.yahoo.com

A Closer Look At R1 RCM Inc.'s (NASDAQ:RCM) Impressive ROE

June 24, 2022 | nasdaq.com

R1 RCM Inc Shares Climb 1.7% Past Previous 52-Week High - Market Mover

June 22, 2022 | finanznachrichten.de

R1 RCM Inc.: R1 RCM Completes Acquisition of Cloudmed

June 11, 2022 | finance.yahoo.com

Is It Time To Consider Buying R1 RCM Inc. (NASDAQ:RCM)?

June 3, 2022 | msn.com

Looking Into R1 RCM's Return On Capital Employed

May 12, 2022 | finance.yahoo.com

Should We Be Delighted With R1 RCM Inc.'s (NASDAQ:RCM) ROE Of 28%?

May 9, 2022 | benzinga.com

7RCM : R1 RCM: Q1 Earnings Insights

May 9, 2022 | seekingalpha.com

R1 RCM Inc. (RCM) CEO Joe Flanagan on Q1 2022 Results - Earnings Call Transcript

May 9, 2022 | seekingalpha.com

R1 RCM and ScionHealth sign a 10-year Revenue Cycle Management partnership

May 9, 2022 | investing.com

R1 RCM Misses Q1 EPS by 1c

May 9, 2022 | finance.yahoo.com

R1 Announces 10-Year End-to-End Revenue Cycle Management Partnership with ScionHealth

May 9, 2022 | finance.yahoo.com

R1 RCM Reports First Quarter 2022 Results

May 6, 2022 | seekingalpha.com

R1 RCM Q1 2022 Earnings Preview

May 6, 2022 | nasdaq.com

R1 RCM Becomes Oversold

May 6, 2022 | benzinga.com

Earnings Outlook For R1 RCM

May 5, 2022 | seekingalpha.com

R1 RCM: Undervalued Stock With 62.5% Upside

May 5, 2022 | finance.yahoo.com

PennyMac Financial (PFSI) Tops Q1 Earnings and Revenue Estimates

May 2, 2022 | finance.yahoo.com

R1 RCM Inc. (RCM) Reports Next Week: Wall Street Expects Earnings Growth

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Management services
Sub-Industry: Health Care Services
Sector: Business Services
Current Symbol: NASDAQ:RCM
Previous Symbol: NYSE:RCM
CUSIP: 00438V10
CIK: 1472595
Web: www.r1rcm.com
Phone: (312) 324-7820
Fax: 302-655-5049
Employees: 22,000
Year Founded: 2003

Company Calendar

Last Earnings: 5/09/2022
Today: 7/03/2022
Next Earnings (Estimated): 8/02/2022
Fiscal Year End: 12/31/2022

Price Target and Rating

Average Stock Price Forecast: $29.00
High Stock Price Forecast: $34.00
Low Stock Price Forecast: $26.00
Forecasted Upside/Downside: +32.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.875
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.31
Trailing P/E Ratio: 70.87
Forward P/E Ratio: 45.77
P/E Growth: 2.54
Net Income: $97.20 million
Net Margins: 6.64%
Pretax Margin: 8.72%
Return on Equity: 29.44%
Return on Assets: 7.27%

Debt

Debt-to-Equity Ratio: 2.06
Current Ratio: 1.54
Quick Ratio: 1.54

Sales & Book Value

Annual Sales: $1.47 billion
Price / Sales: 4.17
Cash Flow: $0.63 per share
Price / Cash Flow: 34.67
Book Value: $1.25 per share
Price / Book: 17.58

Miscellaneous

Outstanding Shares: 279,705,000
Free Float: 113,560,000
Market Cap: $6.15 billion
Optionable: Not Optionable
Beta: 0.86

Social Links

R1 RCM Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" R1 RCM stock.
View analyst ratings for R1 RCM or view top-rated stocks.
What is R1 RCM's stock price forecast for 2022?: 8 analysts have issued 1 year target prices for R1 RCM's stock. Their RCM stock forecasts range from $26.00 to $34.00. On average, they predict R1 RCM's stock price to reach $29.00 in the next twelve months. This suggests a possible upside of 32.0% from the stock's current price.
View analysts' price targets for R1 RCM or view top-rated stocks among Wall Street analysts.
How has R1 RCM's stock performed in 2022?: R1 RCM's stock was trading at $25.49 at the beginning of 2022. Since then, RCM stock has decreased by 13.8% and is now trading at $21.97.
View the best growth stocks for 2022 here.
When is R1 RCM's next earnings date?: R1 RCM is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for R1 RCM.
How were R1 RCM's earnings last quarter?: R1 RCM Inc. (NASDAQ:RCM) posted its quarterly earnings data on Monday, May, 9th. The healthcare provider reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. The healthcare provider had revenue of $385.70 million for the quarter, compared to the consensus estimate of $384.18 million. R1 RCM had a net margin of 6.64% and a trailing twelve-month return on equity of 29.44%. The business's revenue for the quarter was up 12.6% compared to the same quarter last year. During the same quarter last year, the company posted ($2.37) EPS.
View R1 RCM's earnings history.
What guidance has R1 RCM issued on next quarter's earnings?: R1 RCM updated its FY 2022 earnings guidance on Monday, July, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.85 billion-$1.87 billion, compared to the consensus revenue estimate of $1.75 billion.
Who are R1 RCM's key executives?: R1 RCM's management team includes the following people:
Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 51, Pay $2.65M)
Ms. Rachel Wilson, Exec. VP, CFO & Treasurer (Age 49, Pay $1.47M)
Mr. John M. Sparby, Exec. VP of Operations & Delivery and COO (Age 46, Pay $1.01M) (LinkedIn Profile)
Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 51, Pay $911.83k)
Mr. Richard B. Evans Jr., Sr. VP, Corp. Controller & Chief Accounting Officer (Age 54)
Mr. Jay Sreedharan, Chief Technology & Digital Officer
Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
Mr. Corey Perman, Exec. VP of Compliance & Risk
Mr. Sean Radcliffe, Exec. VP, Gen. Counsel & Corp. Sec.
Ms. Kate Sanderson, Exec. VP & Chief HR Officer
What is Joseph Flanagan's approval rating as R1 RCM's CEO?: 253 employees have rated R1 RCM CEO Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among R1 RCM's employees.
Who are some of R1 RCM's key competitors?: Some companies that are related to R1 RCM include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), AMN Healthcare Services (AMN), LHC Group (LHCG), Amedisys (AMED), CorVel (CRVL), MEDNAX (MD), Tivity Health (TVTY) and Cross Country Healthcare (CCRN).
View all of RCM's competitors.

What other stocks do shareholders of R1 RCM own?: Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).
What is R1 RCM's stock symbol?: R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
Who are R1 RCM's major shareholders?: R1 RCM's stock is owned by many different retail and institutional investors. Top institutional investors include Insight Wealth Strategies LLC (0.03%). Company insiders that own R1 RCM stock include Achi Series Lllp Tcp-Asc, Albert Rene Zimmerli, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Michael C Feiner and Richard B Jr Evans.
View institutional ownership trends for R1 RCM.
Which major investors are selling R1 RCM stock?: RCM stock was sold by a variety of institutional investors in the last quarter, including Insight Wealth Strategies LLC. Company insiders that have sold R1 RCM company stock in the last two years include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Michael C Feiner, and Richard B Jr Evans.
View insider buying and selling activity for R1 RCM or view top insider-selling stocks.
How do I buy shares of R1 RCM?: Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is R1 RCM's stock price today?: One share of RCM stock can currently be purchased for approximately $21.97.
How much money does R1 RCM make?: R1 RCM (NASDAQ:RCM) has a market capitalization of $6.15 billion and generates $1.47 billion in revenue each year. The healthcare provider earns $97.20 million in net income (profit) each year or $0.31 on an earnings per share basis.
How many employees does R1 RCM have?: R1 RCM employs 22,000 workers across the globe.
Does R1 RCM have any subsidiaries?: The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
When was R1 RCM founded?: R1 RCM was founded in 2003.
How can I contact R1 RCM?: R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for R1 RCM is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 7/4/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

R1 RCM Stock Forecast, Price & News

R1 RCM MarketRank™ Forecast

Overall MarketRank™

3.4 Analyst's Opinion

2.0 Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

0.0 Dividend Strength

3.0 Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

2.0 News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

2.5 Company Ownership

1.9 Earnings and Valuation

Receive RCM Stock News and Ratings via Email

About R1 RCM (NASDAQ:RCM) Stock

RCM Stock News Headlines

Industry, Sector and Symbol

Company Calendar

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

R1 RCM Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?

What is R1 RCM's stock price forecast for 2022?

How has R1 RCM's stock performed in 2022?

When is R1 RCM's next earnings date?

How were R1 RCM's earnings last quarter?

What guidance has R1 RCM issued on next quarter's earnings?

Who are R1 RCM's key executives?

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

Who are some of R1 RCM's key competitors?

What other stocks do shareholders of R1 RCM own?

What is R1 RCM's stock symbol?

Who are R1 RCM's major shareholders?

Which major investors are selling R1 RCM stock?

How do I buy shares of R1 RCM?

What is R1 RCM's stock price today?

How much money does R1 RCM make?

How many employees does R1 RCM have?

Does R1 RCM have any subsidiaries?

When was R1 RCM founded?

How can I contact R1 RCM?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™